JPS5879926A - ９，１０−ジヒドロエルゴニンの動脈硬化症処置での用途 - Google Patents

９，１０−ジヒドロエルゴニンの動脈硬化症処置での用途

Info

Publication number
JPS5879926A
JPS5879926A JP57183596A JP18359682A JPS5879926A JP S5879926 A JPS5879926 A JP S5879926A JP 57183596 A JP57183596 A JP 57183596A JP 18359682 A JP18359682 A JP 18359682A JP S5879926 A JPS5879926 A JP S5879926A
Authority
JP
Japan
Prior art keywords
dihydroergonine
test
polyarteritis nodosa
rats
arteriosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57183596A
Other languages
English (en)
Japanese (ja)
Inventor
ブライアン・ピ−タ−・リチヤ−ドソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5879926A publication Critical patent/JPS5879926A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP57183596A 1981-10-19 1982-10-18 ９，１０−ジヒドロエルゴニンの動脈硬化症処置での用途 Pending JPS5879926A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8131434 1981-10-19
GB8131434 1981-10-19

Publications (1)

Publication Number Publication Date
JPS5879926A true JPS5879926A (ja) 1983-05-13

Family

ID=10525241

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57183596A Pending JPS5879926A (ja) 1981-10-19 1982-10-18 ９，１０−ジヒドロエルゴニンの動脈硬化症処置での用途

Country Status (3)

Country Link
JP (1) JPS5879926A (fr)
BE (1) BE894696A (fr)
IT (1) IT1189388B (fr)

Also Published As

Publication number Publication date
BE894696A (fr) 1983-04-14
IT1189388B (it) 1988-02-04
IT8249284A0 (it) 1982-10-15
IT8249284A1 (it) 1984-04-15

Similar Documents

Publication Publication Date Title
Boucher et al. Metabolic effects of the consumption of Areca catechu
US4661491A (en) Alfuzosine compositions and use
JP2002532393A (ja) エキソ−ｒ−メカミラミン製剤および治療におけるその使用
JP4669960B2 (ja) 局所麻酔薬を含有する口中用または咽頭部用製剤
JP5243428B2 (ja) 神経細胞の損傷を減少させるための薬学的組成物
JP2008512386A (ja) 改良型ｇｈｂ組成物
US4210670A (en) Antithrombotic agents
JPS5841821A (ja) 最少化された胃の損傷を示す抗炎症組成物
US4748181A (en) Method for treating hypertension with nicotine
PL190896B1 (pl) Zastosowanie lewobupiwakainy w chirurgii dziecięcej
KR100346883B1 (ko) 만성폐색성동맥경화증의치료에유용한카르니틴유도체-함유약제
JP2001518481A (ja) 経口投与のためのセロトニン含有製剤及びその使用方法
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
CN109310669B (zh) 氨基甲酸酯化合物用于预防或治疗三叉神经痛的用途
Boyd The antemetic action of chlorpromazine hydrochloride
WO2023000247A1 (fr) APPLICATION DE L'α-ASARONE DANS LA PRÉPARATION DE MÉDICAMENTS POUR LA PRÉVENTION OU LE TRAITEMENT D'UN ACCIDENT VASCULAIRE CÉRÉBRAL HÉMORRAGIQUE
EP1569635B1 (fr) Utilisation de carnitines pour la prevention et/ou le traitement des troubles causes par l'andropause
JPS5879926A (ja) ９，１０−ジヒドロエルゴニンの動脈硬化症処置での用途
US4686225A (en) Vinpocetine for pulmonary hemorrhage and edema
JP4448447B2 (ja) 筋肉疲労若しくは筋肉損傷およびそれらに起因する疾患の予防治療用組成物
MXPA06006685A (es) Uso de gaboxadol para tratar el insomnio.
US7776913B2 (en) Carnitines for treating or preventing disorders caused by andropause
KR100816140B1 (ko) 일차성 두통의 치료에서 비타민 혼합물의 용도
US5216019A (en) Pain killer
JPH10509729A (ja) 骨粗鬆症治療サイクル用キット